In August we added one new startup to the Access EIS portfolio, investing alongside super angels in each case (for more on our super angels, and our co-investment model, see our dedicated page.
You can read about our new portfolio company below. If you're interested in making an investment and building your own portfolio of promising startups, start here.
Lighthearted AI
Lighthearted AI is a heart disease diagnostics company that aims to make diagnostics quick, cheap and simple. Its precision cardiology platform revolutionises heart disease diagnosis by using laser-based technology and advanced AI.
This innovative approach acquires biomarkers from a distance, enabling quick and accurate diagnostic reports without expert intervention, making the process more accessible and efficient. Its mission is to prevent 10 million deaths by 2030 through the use of a novel non-contact device that detects heart conditions quickly and accurately.
Our angel partner in the round has an IRR of 49% and their previous investments include Aztec, Bloom & Wild, Curve.
Total Round: £750,000.
Stage Pre-revenue.
What is Access EIS?
Read our fund brochure for everything you need to know about Access, from the specifics of our innovative co-investment model to our fees, and how to invest.
Register to learn
more about our data,
fund and venture capital